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Peste des petits ruminants (PPR) is a highly contagious and infectious disease of domestic and wild small ruminants. It is caused by an enveloped non-
segmented negative single-stranded RNA virus (PPRV). The virus is classified in the genus Morbillivirus within the family Paramyxoviridae. The disease
is widely spread in Africa, the Middle-East and South-West Asia. In spite of the existence of efficient vaccines against this disease, no effective or specific
treatments exist for infected animals. The development of a curative tool could consequently be interesting to help in the control of the disease. A
promising approach is the possibility to block the expression of virus genes by RNA interference (RNAi). RNAi is a mechanism of post-transcriptional
gene silencing triggered by double-stranded RNA in a sequence-specific manner. However, a major problem of all antiviral therapies is the emergence of
resistant variants. Many RNA viruses escape RNAi-mediated suppression by counteracting the RNAi machinery through mutations of the targeted region.
CIRAD recently identified three synthetic interfering RNA (siNPPRV1, siNPPRV6 and siNPPRV7) able to prevent in vitro at least 90% of PPRV
replication. The three siRNAs target conserved areas of the essential gene encoding the viral nucleoprotein.
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Peste des petit ruminants viruses (PPRV) 
can escape RNA interference in vitro
In this study, we investigated the ability of PPRV to escape the inhibition
conferred by three previously identified siRNAs after several
consecutive transfections in vitro.
The role of the detected mutations in escaping RNA interference will be soon confirmed by using a reporter gene system based on the
luciferase gene placed under the original or mutated target sequences. The perspectives of this study are also to quantify by QPCR the
dynamics of mutant development versus wild-type virus population after each passage. In parallel, the combination of two or three different
siRNA will be tested and the capacity of the virus to resist to a multi-target treatment will be assessed.
RESULTS
For the three siRNAs, we could recover new virus populations with single
nucleotide mutations that were able to escape from siRNA inhibition.
Interestingly, only for the siNPPRV6, the mutation generated an original
Thr→Met amino acid substitution never observed before in any
morbillivirus ever sequenced at that position.
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